Abstract
Naturally occurring selenium compounds like selenite and selenodiglutathione are metabolized to selenide in plants and animals. This highly reactive form of selenium can undergo methylation and form monomethylated and multimethylated species. These redox active selenium metabolites are of particular biological and pharmacological interest since they are potent inducers of apoptosis in cancer cells. The mammalian thioredoxin and glutaredoxin systems efficiently reduce selenite and selenodiglutathione to selenide. The reactions are non-stoichiometric aerobically due to redox cycling of selenide with oxygen and thiols. Using LDI-MS, we identified that the addition of S-adenosylmethionine (SAM) to the reactions formed methylselenol. This metabolite was a superior substrate to both the thioredoxin and glutaredoxin systems increasing the velocities of the nonstoichiometric redox cycles three-fold. In vitro cell experiments demonstrated that the presence of SAM increased the cytotoxicity of selenite and selenodiglutathione, which could neither be explained by altered selenium uptake nor impaired extra-cellular redox environment, previously shown to be highly important to selenite uptake and cytotoxicity. Our data suggest that selenide and SAM react spontaneously forming methylselenol, a highly nucleophilic and cytotoxic agent, with important physiological and pharmacological implications for the highly interesting anticancer effects of selenium.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / metabolism*
-
Antineoplastic Agents / pharmacology*
-
Biological Transport
-
Cell Line, Tumor
-
Cell Survival / drug effects
-
Cytochromes c / metabolism
-
Disulfides / metabolism
-
Glutaredoxins / metabolism*
-
Glutathione / analogs & derivatives
-
Glutathione / metabolism
-
Humans
-
Intracellular Space / metabolism
-
Methanol / analogs & derivatives*
-
Methanol / metabolism
-
Methanol / pharmacology
-
Methylation
-
Organoselenium Compounds / metabolism*
-
Organoselenium Compounds / pharmacology
-
Oxidation-Reduction
-
Protein Binding
-
S-Adenosylmethionine / metabolism
-
S-Adenosylmethionine / pharmacology
-
Selenium Compounds / metabolism*
-
Selenium Compounds / pharmacology*
-
Superoxides / metabolism
-
Thioredoxin-Disulfide Reductase / metabolism
-
Thioredoxins / metabolism*
Substances
-
Antineoplastic Agents
-
Disulfides
-
Glutaredoxins
-
Organoselenium Compounds
-
Selenium Compounds
-
Superoxides
-
selenodiglutathione
-
Thioredoxins
-
methaneselenol
-
S-Adenosylmethionine
-
Cytochromes c
-
Thioredoxin-Disulfide Reductase
-
Glutathione
-
Methanol
Grants and funding
This investigation was supported by grants from Cancerfonden (The Swedish Cancer Society), Cancer och Allergifonden (The Swedish Cancer and Allergy Foundation), ALF (Stockholm County Council), Radiumhemmets forskningsfonder, Magnus Bergvalls stiftelse, Åke Wibergs stiftelse and Svenska Läkaresällskapet (Swedish Medical Association). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.